LAS VEGAS--(BUSINESS WIRE)--Kronos Incorporated and IBM (NYSE:IBM) today announced a collaboration that brings together the next-generation capabilities of Workforce Dimensions by Kronos and IBM ...
On the heels Kronos Bio’s decision to can its last remaining clinical asset earlier this month, the company said it would roll out “significant expense reduction strategies” to buy itself more time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback